Olga Hartwig


Olga Hartwig is a human and molecular biologist working on in vitro models of the human intestinal barrier. Within the NEW DEAL project, she is investigating the intestinal barrier crossing of nanocarriers for the treatment of inflammatory bowel diseases.


Surfactant-Free Glibenclamide Nanoparticles: Formulation, Characterization and Evaluation of Interactions with Biological Barriers

Arrua E, Hartwig O, Ho D, Loretz B, Murgia X, Salomon C, Lehr C (2021)

Pharmaceutical research 38 (6): 1081-1092DOI: 10.1007/s11095-021-03056-2


Macro- and Microrheological Properties of Mucus Surrogates in Comparison to Native Intestinal and Pulmonary Mucus

Huck B, Hartwig O, Biehl A, Schwarzkopf K, Wagner C, Loretz B, Murgia X, Lehr C (2019)

Biomacromolecules 20 (9): 3504-3512DOI: 10.1021/acs.biomac.9b00780


Oral delivery of macromolecular drugs

Savla R, Hartwig O, Lim Chin W, Loretz B, Lehr C (2018)

Pharm. Technol. Eur. 30 (7): 22-26

The role of mucus on drug transport and its potential to affect therapeutic outcomes

Murgia X, Loretz B, Hartwig O, Hittinger M, Lehr C (2018)

Advanced Drug Delivery Reviews 124: 82-97DOI: 10.1016/j.addr.2017.10.009